NCT06674902

Brief Summary

Aim of the Study The aim of this study is to investigate the differential effects of high-intensity and low-intensity percutaneous electrolysis (PCE) on pain perception and muscle tissue properties in individuals with chronic plantar fasciitis. Research Questions Pain Perception: Does high-intensity PCE induce greater changes in pressure pain threshold (PPT) in the plantar fascia compared to low-intensity PCE in individuals with chronic plantar fasciitis? Muscle Tissue Properties: Does high-intensity PCE reduce stiffness in the plantar fascia to a greater extent than low-intensity PCE in individuals with chronic plantar fasciitis?

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 5, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

November 11, 2024

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2024

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

November 5, 2024

Status Verified

November 1, 2024

Enrollment Period

11 days

First QC Date

November 4, 2024

Last Update Submit

November 4, 2024

Conditions

Keywords

PainElectrolysisshear-wave elastographypain sensitivity

Outcome Measures

Primary Outcomes (1)

  • Pain intensity

    Participants will rate their pain intensity on an 11-point numeric rating scale (NPRS; 0 = no pain; 10 = worst possible pain). They will consider the pain intensity of their first step in the morning, the average pain intensity during the day, and the maximum pain experienced in the past week. The average of all these values will be used to calculate a pain intensity score for the primary analysis.

    Baseline, immediately after

Secondary Outcomes (4)

  • Foot function

    Baseline, immediately after

  • Pain threshold

    Baseline, immediately after

  • Tolerance

    Baseline, during intervention, immediately after

  • Tissue stiffness

    Baseline, immediately after

Study Arms (3)

Experimental 1: Electrolysis with 4 mA

EXPERIMENTAL

A charge of 24 mC will be delivered at 4 mA for 6 seconds, followed by a 54-second pause.

Device: Electrolysis Percutaneous Therapeutic (EPTE)

Experimental 2: Electrolysis with 400 μA

EXPERIMENTAL

A charge of 24 mC will be delivered at 400 µA for 60 seconds.

Device: Electrolysis Percutaneous Therapeutic (EPTE)

Experimental 3: Electrolysis with 600 μA

EXPERIMENTAL

A charge of 36 mC will be delivered at 600 µA for 60 seconds.

Device: Electrolysis Percutaneous Therapeutic (EPTE)

Interventions

EPTE device (Ionclinics, Valencia, Spain)

Experimental 1: Electrolysis with 4 mAExperimental 2: Electrolysis with 400 μAExperimental 3: Electrolysis with 600 μA

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age 18 years or older,
  • unilateral heel pain lasting longer than 3 months,
  • a clinical diagnosis of chronic plantar fasciitis according to the clinical practice guidelines of the Orthopaedic Section of the American Physical Therapy Association (APTA), i.e., sudden onset of pain on the plantar surface of the heel after a period of non-weight bearing, pain that is worse in the morning with the first step, and tenderness to palpation at the proximal attachment site of the plantar fascia.

You may not qualify if:

  • previous lower extremity surgery,
  • the presence of positive neurological signs consistent with nerve root compression,
  • any medical conditions causing heel pain, such as rheumatoid arthritis, diabetes, or peripheral neuropathy,
  • receipt of any foot treatment within the past 6 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursery, Physiotherapy and Podiatry

Madrid, 28040, Spain

Location

Related Publications (3)

  • Alburquerque-Sendin F, Rios-Leon M, Valera-Calero JA, Plaza-Manzano G, Fernandez-de-Las-Penas C, Ortega-Santiago R, Priscila Rodrigues-de-Souza D. Clinical, Psychological, and Neurophysiological Outcomes Associated with Pain and Function in Individuals with Unilateral Plantar Heel Pain. Pain Med. 2022 Aug 31;23(9):1613-1620. doi: 10.1093/pm/pnac018.

    PMID: 35089360BACKGROUND
  • Rios-Leon M, Valera-Calero JA, Ortega-Santiago R, Varol U, Fernandez-de-Las-Penas C, Plaza-Manzano G. Analyzing the Interaction between Clinical, Neurophysiological and Psychological Outcomes Underlying Chronic Plantar Heel Pain: A Network Analysis Study. Int J Environ Res Public Health. 2022 Aug 18;19(16):10301. doi: 10.3390/ijerph191610301.

    PMID: 36011936BACKGROUND
  • Valera-Calero JA, Sanchez-Mayoral-Martin A, Varol U. Short-term effectiveness of high- and low-intensity percutaneous electrolysis in patients with patellofemoral pain syndrome: A pilot study. World J Orthop. 2021 Oct 18;12(10):781-790. doi: 10.5312/wjo.v12.i10.781. eCollection 2021 Oct 18.

    PMID: 34754834BACKGROUND

MeSH Terms

Conditions

Fasciitis, PlantarPain

Condition Hierarchy (Ancestors)

FasciitisMusculoskeletal DiseasesFoot DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Juan Antonio Valera-Calero

    Universidad Complutense de Madrid

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A triple-blinded, pilot randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

November 4, 2024

First Posted

November 5, 2024

Study Start

November 11, 2024

Primary Completion

November 22, 2024

Study Completion

November 30, 2024

Last Updated

November 5, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations